Dr Horton Stock Price To Earnings To Growth
| HO2 Stock | EUR 154.04 0.06 0.04% |
DR Horton fundamentals help investors to digest information that contributes to DR Horton's financial success or failures. It also enables traders to predict the movement of HO2 Stock. The fundamental analysis module provides a way to measure DR Horton's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DR Horton stock.
HO2 |
DR Horton Company Price To Earnings To Growth Analysis
DR Horton's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current DR Horton Price To Earnings To Growth | 1.80 X |
Most of DR Horton's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DR Horton is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, DR Horton has a Price To Earnings To Growth of 1.7973 times. This is 29.79% lower than that of the Consumer Cyclical sector and 110.43% lower than that of the Residential Construction industry. The price to earnings to growth for all Germany stocks is 63.25% higher than that of the company.
HO2 Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DR Horton's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DR Horton could also be used in its relative valuation, which is a method of valuing DR Horton by comparing valuation metrics of similar companies.DR Horton is currently under evaluation in price to earnings to growth category among its peers.
HO2 Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 31.96 B | |||
| Shares Outstanding | 343.39 M | |||
| Shares Owned By Insiders | 14.53 % | |||
| Shares Owned By Institutions | 88.85 % | |||
| Price To Earning | 9.45 X | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 0.87 X | |||
| Revenue | 33.48 B | |||
| Gross Profit | 10.07 B | |||
| EBITDA | 7.65 B | |||
| Net Income | 5.86 B | |||
| Cash And Equivalents | 637.7 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 6.07 B | |||
| Debt To Equity | 37.90 % | |||
| Current Ratio | 7.18 X | |||
| Book Value Per Share | 58.71 X | |||
| Cash Flow From Operations | 561.8 M | |||
| Earnings Per Share | 15.11 X | |||
| Price To Earnings To Growth | 1.80 X | |||
| Target Price | 111.69 | |||
| Number Of Employees | 13.24 K | |||
| Beta | 1.53 | |||
| Market Capitalization | 30.06 B | |||
| Total Asset | 30.35 B | |||
| Z Score | 3.4 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.87 % | |||
| Net Asset | 30.35 B | |||
| Last Dividend Paid | 0.93 |
About DR Horton Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DR Horton's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DR Horton using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DR Horton based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in HO2 Stock
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in HO2 Stock please use our How to Invest in DR Horton guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.